Literature DB >> 351403

Thrombotic thrombocytopenic purpura--a deficiency of plasma factors regulating platelet-vessel-wall interaction?

G Remuzzi, R Misiani, G Mecca, G de Gaetano, M B Donati.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 351403     DOI： 10.1056/NEJM197808102990617

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  5 in total

1.  Treatment of the childhood haemolytic uraemic syndrome with plasma. A multicentre randomized controlled trial. The French Society of Paediatric Nephrology.

Authors:  C Loirat; E Sonsino; N Hinglais; J P Jais; P Landais; J Fermanian
Journal:  Pediatr Nephrol       Date:  1988-07       Impact factor: 3.714

2.  Inhibition of platelet-aggregating activity in thrombotic thrombocytopenic purpura plasma by normal adult immunoglobulin G.

Authors:  E C Lian; P T Mui; F A Siddiqui; A Y Chiu; L L Chiu
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

3.  Plasma exchange in thrombotic thrombocytopenic purpura.

Authors:  E B Toffelmire; W F Clark; P E Cordy; A L Linton; R C Lohmann
Journal:  Can Med Assoc J       Date:  1984-12-01       Impact factor: 8.262

4.  Haemolytic uraemic syndrome: therapeutic effect of plasma infusion.

Authors:  R Misiani; A C Appiani; A Edefonti; E Gotti; A Bettinelli; M Giani; E Rossi; G Remuzzi; G Mecca
Journal:  Br Med J (Clin Res Ed)       Date:  1982-11-06

5.  [Thrombotic thrombocytopenic purpura].

Authors:  C Aul; R E Scharf; T Königshausen; W Schneider
Journal:  Klin Wochenschr       Date:  1985-02-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.